Conference abstract · 18 Sep 2017
Conference abstractPublished 18 Sep 2017
Metabolic dysregulation drives sensitivity after PI3K/mTOR inhibition in HNSCC
University of Texas MD Anderson Cancer Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Genomic alterations in the PI3K/mTOR pathway occur in 54% of HNSCC patients. However, clinical trials of PI3K/mTOR pathway inhibitors had limited success even in those tumors with pathway alterations, including PIK3CA mutations. To identify mechanisms driving sensitivity in HNSCC, we tested the efficacy of 7 PI3K/mTOR pathway inhibitors in 59 HNSCC cell lines and classified the cell lines as sensitive and resistant to drugs based on Cmax (peak plasma concentration). After PI3K/mTOR inhibition, the sensitive lines showed significantly reduced clonogenic growth in vitro (0.4/ 0.9-fold in HN31/PCI15B; P<0.05) and significant tumor growth inhibition in vivo using Orthotopic oral xenograft mouse models (1.7 and 2-fold in UMSCC22A and HN31; P<0.01). As no canonical pathways account for the underlying mechanism of sensitivity, we measured the level of 301 proteins by reverse phase protein array (RPPA) in 3 sensitive and 3 resistant lines after GSK2126458 treatment. The protein levels of glutaminase and glutamate dehydrogenase were differentially regulated in sensitive lines. Thus, we hypothesized that PI3K/mTOR inhibition in responding cell lines induced reactive oxygen species (ROS)-mediated apoptosis via metabolic alterations. Consistent with this hypothesis, sensitive lines exhibited increased ROS production after GSK2126458 treatment. It also increased the levels of phosphogluconate dehydrogenase (PGD) and decreased levels of glutamate. Metabolic pathway inhibitors targeting glutaminolysis, in combination with GSK2126458 decreased cell viability in resistant cell lines. In addition, we identified that sensitive HNSCC cells that underwent apoptosis after PI3K/mTOR pathway inhibition harbored NOTCH1 mutation. The underlying mechanism may involve the effect of NOTCH pathway on tumor metabolism and ROS production. This work is significant because inactivating NOTCH1 mutations, which occur in 18% of HNSCC patients and SCCs of the lung, esophagus, and other sites, may serve as a biomarker for response. Our future work may uncover previously unknown crosstalk between the PI3K/mTOR and NOTCH pathways in SCCs.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 27 Sep 2017
G0S2 represses PI3K/AKT/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in estrogen receptor-positive breast cancer cells
Article · 18 Aug 2025
The anti-inflammatory effect of Artemisia absinthium extract on cell growth through targeting PI3K/Akt/mTOR pathway in human hepatocellular carcinoma cell line
Article · 20 Feb 2024
Targeting the PI3K/Akt/mTOR Signaling Pathway in Colorectal Cancer Treatment: Current Insights and Future Perspectives
Conference abstract · 20 Jul 2015
PI3K/Akt/mTOR pathway dual inhibitor bez235 suppresses the growth of colon cancer stem cells through reduction of their stemness
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Vaishnavi Sambandam”
- BylineArticles whose byline prints “Li Shen”
- BylineArticles whose byline prints “Pan Ton”
- BylineArticles whose byline prints “Tuhina Mazumdar”
- BylineArticles whose byline prints “Jeremy Jong”
- BylineArticles whose byline prints “Curtis Pickering”
- BylineArticles whose byline prints “Jeffrey N Myers”
- BylineArticles whose byline prints “Jing Wang”

